A qualitative study on the impact of long-distance travel for gynecologic cancer care
- PMID: 34692967
- PMCID: PMC8511836
- DOI: 10.1016/j.gore.2021.100868
A qualitative study on the impact of long-distance travel for gynecologic cancer care
Abstract
Background: Women with gynecologic malignancies experience improved clinical outcomes when they are treated by gynecologic oncologists and in high-volume cancer centers. However, geography is a major barrier to high-volume care for patients. This qualitative study was undertaken to identify facilitators and barriers to patients traveling long distances for gynecologic cancer care.
Methods: Semi-structured interviews were conducted with 19 women with gynecologic malignancies traveling >50 miles for treatment at Wake Forest Comprehensive Cancer Center. Eight interviews included caregivers. Four interview domains focused on personal challenges and coping strategies related to accessing cancer care.
Results: Mean distance traveled for care was 87 miles (range: 54-218). Most participants reported that recommendations from physicians, friends, and family motivated travel. 10/19 participants were aware of closer sites for cancer care; 5 had unfavorable experiences elsewhere. Barriers to travel included time, cost, childcare, difficulty navigating, and physical discomfort. Social support was an important facilitator of travel for care; some patients utilized loaned money or vehicles. Participants reported significant energy expenditure scheduling travel, coordinating time off work, and arranging overnight stays near the cancer center. Suggestions for care improvement included travel vouchers, transportation assistance, signage and personnel to help with navigation, and appointments later in the day. Participants supported in-person oncologist outreach to rural areas and appointments via telemedicine; few preferred the current infrastructure.
Conclusion: Patients who travel long distances for gynecologic cancer care encounter significant burdens and rely heavily on social and financial support. Interventions should be developed and evaluated to reduce the burden of long-distance travel and develop efficient methods of outreach, including telemedicine.
© 2021 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
A qualitative study of patients' attitudes towards telemedicine for gynecologic cancer care.Gynecol Oncol. 2022 Apr;165(1):155-159. doi: 10.1016/j.ygyno.2022.01.035. Epub 2022 Feb 9. Gynecol Oncol. 2022. PMID: 35148890 Free PMC article.
-
Geographic disparities amongst patients with gynecologic malignancies at an urban NCI-designated cancer center.Gynecol Oncol. 2015 Jun;137(3):497-502. doi: 10.1016/j.ygyno.2015.03.010. Epub 2015 Mar 17. Gynecol Oncol. 2015. PMID: 25795262
-
Barriers around access to abortion experienced by rural women in New South Wales, Australia.Rural Remote Health. 2016 Jan-Mar;16(1):3538. Epub 2016 Mar 18. Rural Remote Health. 2016. PMID: 26987999
-
Patient-Reported Barriers and Facilitators to Seeking and Accessing Support in Gynecologic and Breast Cancer Survivors With Sexual Problems: A Systematic Review of Qualitative and Quantitative Studies.J Sex Med. 2020 Jul;17(7):1326-1358. doi: 10.1016/j.jsxm.2020.03.004. Epub 2020 Apr 21. J Sex Med. 2020. PMID: 32331967
-
Examining the Effect of Travel Distance to Pediatric Cancer Centers and Rurality on Survival and Treatment Experiences: A Systematic Review.J Pediatr Hematol Oncol. 2021 Jul 1;43(5):159-171. doi: 10.1097/MPH.0000000000002095. J Pediatr Hematol Oncol. 2021. PMID: 33625091
Cited by
-
National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial.Breast Cancer Res Treat. 2024 Jan;203(2):317-328. doi: 10.1007/s10549-023-07114-8. Epub 2023 Oct 20. Breast Cancer Res Treat. 2024. PMID: 37864105 Free PMC article.
-
Distance Traveled and Disparities in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.Ann Surg Oncol. 2024 Feb;31(2):1035-1048. doi: 10.1245/s10434-023-14469-1. Epub 2023 Nov 19. Ann Surg Oncol. 2024. PMID: 37980711
-
Qualitative Interview Study of Gynecologic Oncologist Utilization of Recommended Same-Day Discharge Following Minimally Invasive Hysterectomy.J Pers Med. 2022 Jun 30;12(7):1082. doi: 10.3390/jpm12071082. J Pers Med. 2022. PMID: 35887579 Free PMC article.
-
Improving Access to Radiotherapy in Gauteng: A Framework for Equitable Cancer Care.Int J Environ Res Public Health. 2025 Jul 3;22(7):1071. doi: 10.3390/ijerph22071071. Int J Environ Res Public Health. 2025. PMID: 40724138 Free PMC article.
-
A qualitative study of patients' attitudes towards telemedicine for gynecologic cancer care.Gynecol Oncol. 2022 Apr;165(1):155-159. doi: 10.1016/j.ygyno.2022.01.035. Epub 2022 Feb 9. Gynecol Oncol. 2022. PMID: 35148890 Free PMC article.
References
LinkOut - more resources
Full Text Sources